Coming soon: A blood test for Alzheimer's disease?

January 17, 2019

People with symptoms of Alzheimer's disease (AD), such as cognitive difficulties, behavior changes and mood swings, may wait months or even years to get a definitive diagnosis. That's because doctors lack a simple, accurate and inexpensive test for it. But according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, researchers are getting much closer to developing the elusive blood test for AD.

About 5.5 million Americans are living with AD, according to the National Institute on Aging. Most do not seek treatment until their symptoms are well advanced, freelance contributor Jyoti Madhusoodanan writes. By then, substantial and irreversible damage to the brain has already occurred. Current tests for AD, such as positron emission tomography (PET) and lumbar puncture, are invasive, cost thousands of dollars and aren't covered by most health insurance plans in the U.S. For nearly 20 years, researchers have been trying to develop a blood test for AD, but they've been stymied by the low amounts of potential biomarkers in blood.

Recently, new biomarkers and assays have moved a reliable blood test closer to the clinic. For example, instead of measuring the total amount of amyloid -- the protein that forms clumps in the brains of AD patients -- in blood, researchers can more accurately diagnose AD by looking at ratios of different peptides that form when amyloid breaks down. Sensitive new assays can detect smaller amounts of these peptides in blood. These and other developments have made many researchers optimistic that a blood test for AD will be available within the next five years. Such a test would not only aid in diagnosis, but might also help in the search for better AD treatments because it could identify participants for clinical trials.
-end-
The article was produced in partnership with ACS Central Science, ACS' fully open-access journal. Read the original version here.

The article, "A blood test for Alzheimer's disease draws near," is freely available here.

The American Chemical Society, the world's largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.

Follow us on Twitter | Facebook

American Chemical Society

Related Aging Articles from Brightsurf:

Surprises in 'active' aging
Aging is a process that affects not only living beings.

Aging-US: 'From Causes of Aging to Death from COVID-19' by Mikhail V. Blagosklonny
Aging-US recently published ''From Causes of Aging to Death from COVID-19'' by Blagosklonny et al. which reported that COVID-19 is not deadly early in life, but mortality increases exponentially with age - which is the strongest predictor of mortality.

Understanding the effect of aging on the genome
EPFL scientists have measured the molecular footprint that aging leaves on various mouse and human tissues.

Muscle aging: Stronger for longer
With life expectancy increasing, age-related diseases are also on the rise, including sarcopenia, the loss of muscle mass due to aging.

Aging memories may not be 'worse, 'just 'different'
A study from the Department of Psychological & Brain Sciences in Arts & Sciences adds nuance to the idea that an aging memory is a poor one and finds a potential correlation between the way people process the boundaries of events and episodic memory.

A new biomarker for the aging brain
Researchers at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan have identified changes in the aging brain related to blood circulation.

Scientists invented an aging vaccine
A new way to prevent autoimmune diseases associated with aging like atherosclerosis, Alzheimer's disease, and Parkinson's disease was described in the article.

The first roadmap for ovarian aging
Infertility likely stems from age-related decline of the ovaries, but the molecular mechanisms that lead to this decline have been unclear.

Researchers discover new cause of cell aging
New research from the USC Viterbi School of Engineering could be key to our understanding of how the aging process works.

Deep Aging Clocks: The emergence of AI-based biomarkers of aging and longevity
The advent of deep biomarkers of aging, longevity and mortality presents a range of non-obvious applications.

Read More: Aging News and Aging Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.